Logo
Logo

About Adagrasib API

Product
  • Therapeutic CategoryAnti-Cancer/ Oncology

  • CAS Number

    2326521-71-3

  • API Technology

    Synthetic

  • Dose Form

    Oral Solid/Tablets

  • Dr Reddy's Development Status

    Under Development

Related APIs

Abiraterone Acetate

Anti-Cancer/ Oncology

arrow

Adagrasib

Anti-Cancer/ Oncology

arrow

Apalutamide (Amorphous & Form B)

Anti-Cancer/ Oncology

arrow

Azacitidine

Anti-Cancer/ Oncology

arrow

Bendamustine Hydrochloride

Anti-Cancer/ Oncology

arrow

Bortezomib

Anti-Cancer/ Oncology

arrow

Cabazitaxel

Anti-Cancer/ Oncology

arrow

Cabozantinib S-Malate

Anti-Cancer/ Oncology

arrow

Capecitabine

Anti-Cancer/ Oncology

arrow

Carfilzomib

Anti-Cancer/ Oncology

arrow

Darolutamide

Anti-Cancer/ Oncology

arrow

Dasatinib (Monohydrate)

Anti-Cancer/ Oncology

arrow

Decitabine

Anti-Cancer/ Oncology

arrow

Deucravacitinib

Anti-Cancer/ Oncology

arrow

Fruquintinib

Anti-Cancer/ Oncology

arrow

Gemcitabine Hydrochloride

Anti-Cancer/ Oncology

arrow

Granisteron

Anti-Cancer/ Oncology

arrow

Lenalidomide (Form A)

Anti-Cancer/ Oncology

arrow

Lenvatinib Mesylate ( MIBK Solvate)

Anti-Cancer/ Oncology

arrow

Lomustine

Anti-Cancer/ Oncology

arrow

Midostaurin

Anti-Cancer/ Oncology

arrow

Nilotinib Hydrochloride Monohydrate (Form B)

Anti-Cancer/ Oncology

arrow

Olaparib (Form A)

Anti-Cancer/ Oncology

arrow

Palbociclib

Anti-Cancer/ Oncology

arrow

Pazopanib

Anti-Cancer/ Oncology

arrow

Pemetrexed Disodium Heptahydrate

Anti-Cancer/ Oncology

arrow

Pirtobrutinib

Anti-Cancer/ Oncology

arrow

Pomalidomide

Anti-Cancer/ Oncology

arrow

Relugolix

Anti-Cancer/ Oncology

arrow

Ripretinib

Anti-Cancer/ Oncology

arrow

Tucatinib

Anti-Cancer/ Oncology

arrow

Venetoclax

Anti-Cancer/ Oncology

arrow

Zanubrutinib

Anti-Cancer/ Oncology

arrow

Zoledronic Acid

Anti-Cancer/ Oncology

arrow

Cabozantinib Hydrochloride

Anti-Cancer/ Oncology

arrow

Eribulin Mesylate

Anti-Cancer/ Oncology

arrow

Enzalutamide (Crystalline & Premix)

Anti-Cancer/ Oncology

arrow

Lenvatinib Mesylate (Form-C)

Anti-Cancer/ Oncology

arrow

Niraparib Tosylate

Anti-Cancer/ Oncology

arrow

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone

Disclaimer

No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.